UNITED THERAPEUTICS (UTH BE) stock market data APIs
€436.2151
0.7(0.2%)
as of December 23, 2025
Try our APIs with
free plan!
UNITED THERAPEUTICS Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for UTH.BE.
Prev. Close
436.2151
Open
436.9151
High
437.7753
Low
435.2068
52 wk Range
237.2-443
Market Cap
7 520 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get UNITED THERAPEUTICS data using free add-ons & libraries
Get UNITED THERAPEUTICS Fundamental Data
UNITED THERAPEUTICS Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
UNITED THERAPEUTICS News
New
Alger Russell Innovation Index Updates for Fourth Quarter 2025
NEW YORK, Dec. 15, 2025 /PRNewswire/ -- Fred Alger Management, LLC ("Alger"), a privately held growth equity investment manager, today announced the quarterly rebalancing of the Alger Russell Innovat...
United Therapeutics (UTHR): Revisiting Valuation After Strong Multi‑Year Share Price Gains
United Therapeutics (UTHR) has quietly kept shareholders happy this year, with the stock up about 32% year to date and roughly 72% over the past 3 years despite recent week to week softness. See our ...
This Gold Stock Hits A High, With Miner Poised For Huge Swing To Profit
This gold stock recovered from an October sell-off and hit a record high. It and two other names show rising profit estimates. Continue Reading
Flurry of Bullish Inflows Sends United Therapeutics Higher
UTHR is a biotechnology company that develops and sells treatments for chronic and life-threatening conditions, with products including Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
